[Effect of ACTH, metopirone and dexamethasone on urinary excretion of 3-methoxy-4-hydroxymandelic acid (VMA) in patients following cerebral stroke].
D000311:Adrenal Glands / Q000187:drug effects; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology*; D000328:Adult; D000368:Aged; D002561:Cerebrovascular Disorders / Q000378:metabolism / Q000652:urine*; D003907:Dexamethasone / Q000494:pharmacology*; D006801:Humans; D008797:Metyrapone / Q000494:pharmacology*; D008875:Middle Aged; D010913:Pituitary-Adrenal System / Q000187:drug effects; D013053:Spectrophotometry; D013997:Time Factors; D014642:Vanilmandelic Acid / Q000652:urine*
D014642:Vanilmandelic Acid; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D008797:Metyrapone
Wpływ ACTH, metopironu i deksametazonu na wydalanie kwasu 3-metoksy-4-hydroksy-migdałowego (MHM) z moczem u chorych po udarze mózgu.